These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 4369217

  • 1. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T, Schein PS, McMenamin MG, Cooney DA.
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [Abstract] [Full Text] [Related]

  • 2. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H, Yamamoto H.
    Princess Takamatsu Symp; 1983 Sep; 13():297-308. PubMed ID: 6317640
    [Abstract] [Full Text] [Related]

  • 3. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J, Welsh N, Sandler S.
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF, Grose M, Videtic GM, Marliss EB.
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [Abstract] [Full Text] [Related]

  • 5. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N, Janjua MZ.
    J Ayub Med Coll Abbottabad; 2001 Mar; 13(3):26-30. PubMed ID: 11873395
    [Abstract] [Full Text] [Related]

  • 6. Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
    Junod A, Lambert AE, Stauffacher W, Renold AE.
    J Clin Invest; 1969 Nov; 48(11):2129-39. PubMed ID: 4241908
    [Abstract] [Full Text] [Related]

  • 7. Tilapia islet grafts are highly alloxan-resistant.
    Xu BY, Morrison CM, Yang H, Wright JR.
    Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
    [Abstract] [Full Text] [Related]

  • 8. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W, Schott-Ohly P, Schulte im Walde S, Gleichmann H.
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic uptake of [2-(14)C]alloxan.
    Malaisse WJ, Doherty M, Ladrière L, Malaisse-Lagae F.
    Int J Mol Med; 2001 Mar; 7(3):311-5. PubMed ID: 11179513
    [Abstract] [Full Text] [Related]

  • 10. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
    Sandler S, Swenne I.
    Diabetes Res; 1985 Sep; 2(5):255-8. PubMed ID: 2933209
    [Abstract] [Full Text] [Related]

  • 11. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
    Doi K.
    Nihon Naibunpi Gakkai Zasshi; 1975 Mar 20; 51(3):129-47. PubMed ID: 169168
    [Abstract] [Full Text] [Related]

  • 12. DNA synthesis in pancreatic islet and acinar cells in rats with streptozotocin-induced diabetes.
    Hamming NA, Reynolds WA.
    Horm Metab Res; 1977 Mar 20; 9(2):114-6. PubMed ID: 140841
    [Abstract] [Full Text] [Related]

  • 13. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
    Kishore A, Nampurath GK, Mathew SP, Zachariah RT, Potu BK, Rao MS, Valiathan M, Chamallamudi MR.
    Chem Biol Interact; 2009 Feb 12; 177(3):242-6. PubMed ID: 19038238
    [Abstract] [Full Text] [Related]

  • 14. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
    Schein PS, Cooney DA, McMenamin MG, Anderson T.
    Biochem Pharmacol; 1973 Oct 15; 22(20):2625-31. PubMed ID: 4357891
    [No Abstract] [Full Text] [Related]

  • 15. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI, Gysemans CA, Ladrière L, D'Hertog W, Hagenbrock J, Overbergh L, Eizirik DL, Mathieu C.
    Diabetes; 2007 Aug 15; 56(8):2169-73. PubMed ID: 17473223
    [Abstract] [Full Text] [Related]

  • 16. Multiple low-dose and single high-dose treatments with streptozotocin do not generate nitric oxide.
    Papaccio G, Pisanti FA, Latronico MV, Ammendola E, Galdieri M.
    J Cell Biochem; 2000 Feb 15; 77(1):82-91. PubMed ID: 10679819
    [Abstract] [Full Text] [Related]

  • 17. NAD synthesis from nicotinic acid by the hepatocytes prepared from diabetic rats.
    Shin M, Maeda S, Hashimoto Y, Sano K, Umezawa C.
    Int J Vitam Nutr Res; 1995 Feb 15; 65(2):143-6. PubMed ID: 7591535
    [Abstract] [Full Text] [Related]

  • 18. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC, Baumann E, Vezys V, Buckingham F.
    J Autoimmun; 1997 Feb 15; 10(1):17-25. PubMed ID: 9080296
    [Abstract] [Full Text] [Related]

  • 19. [Streptozotocin].
    Rudas B.
    Arzneimittelforschung; 1972 May 15; 22(5):830-61. PubMed ID: 4340253
    [No Abstract] [Full Text] [Related]

  • 20. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
    Gunnarsson R, Berne C, Hellerström C.
    Biochem J; 1974 Jun 15; 140(3):487-94. PubMed ID: 4374939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.